Related Experiment Video
Updated: Jun 22, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular
Mhairi K Sigrist1, Adeera Levin, Lee Er
1School of Graduate Entry Medicine and Health, The University of Nottingham, Derby, UK. msigrist@providencehealth.bc.ca
Insights
Osteoprotegerin (OPG) and vascular calcification predict death in chronic kidney disease (CKD) patients. This study highlights OPG as an independent predictor of mortality, beyond its association with vascular damage.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease is the primary cause of mortality in chronic kidney disease (CKD) patients.
- Mechanisms underlying vascular damage in CKD are not fully elucidated.
- Vascular calcification (VC) is a known contributor to adverse outcomes in CKD.
Purpose of the Study:
- To prospectively investigate novel mediators of vascular damage in CKD.
- To assess the combined impact of vascular calcification and novel mediators on patient survival.
- To identify predictors of mortality in patients with chronic kidney disease.
Main Methods:
- 134 CKD patients (60 hemodialysis, 28 peritoneal dialysis, 46 stage 4) were followed for 40 months.
- Vascular calcification (VC) assessed via CT scan; circulating osteoprotegerin (OPG), Fetuin-A, and hs-CRP measured.
- Standard clinical and biochemical analyses performed.
Main Results:
- 31 deaths occurred over 40 months, with all deceased patients exhibiting significant VC.
- Male gender, elevated OPG levels (>25 pmol/L), and hypoalbuminemia were associated with increased mortality risk.
- Osteoprotegerin (OPG) emerged as an independent predictor of mortality, irrespective of C-reactive protein (CRP) levels.
Conclusions:
- Vascular calcification (VC) and low albumin predict death in advanced CKD stages.
- Osteoprotegerin (OPG) is independently associated with a negative prognosis in CKD patients.
- Further research is needed to elucidate the mechanisms linking OPG to vascular damage and mortality in CKD.
Background:
Cardiovascular disease is the leading cause of death in the chronic kidney disease (CKD) population. The mechanisms of vascular damage are not fully understood. The objective of this study was to prospectively investigate the importance of novel mediators of vascular damage, in conjunction with vascular calcification (VC), on survival.
Methods:
A total of 134 subjects [60 haemodialysis (HD), 28 peritoneal dialysis (PD) and 46 CKD stage 4] were studied. All survivors completed 40 months of follow-up. VC was measured using multi-slice spiral CT of the superficial femoral artery. Circulating osteoprotegerin (OPG), Fetuin-A and high sensitivity C-reactive protein (hs-CRP) were measured in addition to standard clinical biochemical analysis.
Results:
After a 40-month follow-up, 31 patients had died (27 men and 4 women). Of 31 subjects, 31 had evidence of significant VC. The majority of deaths were in the HD group (48%), 36% were PD subjects and 16% were CKD subjects. The outcome of interest was survival at the end of follow-up. Multivariate logistical regression analysis revealed male gender [OR 8.06 (1.34-48.450) P = 0.02], OPG >25 pmol/L [OR 5.31(1.35-20.88) P = 0.02] and hypoalbuminaemia [OR 0.26 (0.12-0.56) P < 0.01], were associated with increased odds of death.
Conclusion:
We have previously reported that VC and low albumin predict death in CKD stages 4 and 5 over a 2-year follow-up period. These data show that OPG, independent of CRP, is also associated with a negative outcome. The mechanisms remain to be elucidated; however, it is likely that they are associated with vascular damage through mechanisms in addition to VC.
Related Concept Videos
Osteoclasts in Bone Remodeling
Chronic Kidney Disease II: Clinical Manifestations
Skeleton and Calcium Homeostasis
Chronic Kidney Disease I: Introduction
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
